Karoly Nikolich
Chairman
Scientific Advisory Board
AngioChem
United States of America
Biography
Dr. Karoly Nikolich has been director and SAB member of several biotech companies. He served as CEO of Amnestix, Inc, between 2007 and 2010; during this time he was also US partner and advisor of dievini investments. Earlier, he was executive director of the Neuroscience Institute at Stanford University. Dr. Nikolich co-founded several biotech companies, including AGY Therapeutics with Bob Swanson in 1998. He started his career in the biotech industry as a scientist at Genentech during the early 1980s where he initiated and built the company’s first neuroscience research program. Later, he was VP Research at Lynx Therapeutics (acquired by Solexa/Illumina). Dr. Nikolich is currently Consulting Professor at Stanford University Medical School and was formerly Adjunct Professor at the University of Southern California. As a scientist he co-authored 130 publications.
Research Interest
neuroscience research